Sunday, April 11, 2010

Byetta may have cancer risk, FDA says | cincinnati.com

Amylin Pharmaceuticals Inc. and Eli Lilly & Co.'s long-acting Byetta may be tied to increased cancer risk, a top U.S. regulator said, raising concerns that the experimental diabetes drug may need strict warnings.

Posted via web from Jack's posterous

No comments: